Acumen Pharmaceuticals
ABOS
ABOS
61 hedge funds and large institutions have $113M invested in Acumen Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+1
Holders Change %
+1.67%
% of All Funds
0.98%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
17
Reduced
22
Closed
9
Calls
$206K
Puts
$284K
Net Calls
-$78K
Net Calls Change
-$401K
Top Buyers
| 1 |
1
Walleye Capital
New York
|
$798K |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$548K |
| 3 |
3
Hudson Bay Capital Management
Stamford,
Connecticut
|
$1.45M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$271K |
| 5 |
5
Jane Street
New York
|
$303K |
